Vitrolife AB (publ) (VTRLY)
Vitrolife AB (publ) Statistics
Share Statistics
Vitrolife AB (publ) has 135.42M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 135.42M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 75.02M |
| Failed to Deliver (FTD) Shares | 94 |
| FTD / Avg. Volume | 218.6% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 54.76 and the forward PE ratio is null. Vitrolife AB (publ)'s PEG ratio is -0.48.
| PE Ratio | 54.76 |
| Forward PE | n/a |
| PS Ratio | 7.78 |
| Forward PS | n/a |
| PB Ratio | 2.06 |
| P/FCF Ratio | 30.97 |
| PEG Ratio | -0.48 |
Enterprise Valuation
Vitrolife AB (publ) has an Enterprise Value (EV) of 29.04B.
| EV / Sales | 8.05 |
| EV / EBITDA | 37.09 |
| EV / EBIT | 32.02 |
| EV / FCF | 32.02 |
Financial Position
The company has a current ratio of 3.34, with a Debt / Equity ratio of 0.15.
| Current Ratio | 3.34 |
| Quick Ratio | 2.74 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 2.67 |
| Debt / FCF | 2.3 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 3.76% and Return on Invested Capital is 3.53%.
| Return on Equity | 3.76% |
| Return on Assets | 2.94% |
| Return on Invested Capital | 3.53% |
| Revenue Per Employee | $3.14M |
| Profits Per Employee | $446.09K |
| Employee Count | 1,150 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 3.48 |
Taxes
| Income Tax | 160M |
| Effective Tax Rate | 23.74% |
Stock Price Statistics
The stock price has increased by 35.34% in the last 52 weeks. The beta is 1.91, so Vitrolife AB (publ)'s price volatility has been higher than the market average.
| Beta | 1.91 |
| 52-Week Price Change | 35.34% |
| 50-Day Moving Average | 18 |
| 200-Day Moving Average | 19.77 |
| Relative Strength Index (RSI) | 22.66 |
| Average Volume (20 Days) | 43 |
Income Statement
In the last 12 months, Vitrolife AB (publ) had revenue of 3.61B and earned 513M in profits. Earnings per share was 3.79.
| Revenue | 3.61B |
| Gross Profit | 2.14B |
| Operating Income | 783M |
| Net Income | 513M |
| EBITDA | 783M |
| EBIT | 783M |
| Earnings Per Share (EPS) | 3.79 |
Balance Sheet
The company has 1.14B in cash and 2.09B in debt, giving a net cash position of -954M.
| Cash & Cash Equivalents | 1.14B |
| Total Debt | 2.09B |
| Net Cash | -954M |
| Retained Earnings | -1.61B |
| Total Assets | 16.63B |
| Working Capital | 1.67B |
Cash Flow
In the last 12 months, operating cash flow was 907M and capital expenditures 0, giving a free cash flow of 907M.
| Operating Cash Flow | 907M |
| Capital Expenditures | 0 |
| Free Cash Flow | 907M |
| FCF Per Share | 6.7 |
Margins
Gross margin is 59.27%, with operating and profit margins of 21.7% and 14.21%.
| Gross Margin | 59.27% |
| Operating Margin | 21.7% |
| Pretax Margin | 18.68% |
| Profit Margin | 14.21% |
| EBITDA Margin | 21.7% |
| EBIT Margin | 21.7% |
| FCF Margin | 25.13% |
Dividends & Yields
VTRLY pays an annual dividend of $0.05, which amounts to a dividend yield of 0.36%.
| Dividend Per Share | $0.05 |
| Dividend Yield | 0.36% |
| Dividend Growth (YoY) | -46% |
| Payout Ratio | 13.1% |
| Earnings Yield | 1.83% |
| FCF Yield | 3.23% |
Analyst Forecast
Currently there are no analyst rating for VTRLY.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Nov 2, 2018. It was a forward split with a ratio of 5:4.
| Last Split Date | Nov 2, 2018 |
| Split Type | forward |
| Split Ratio | 5:4 |
Scores
| Altman Z-Score | 0.76 |
| Piotroski F-Score | 8 |